|
GB0603683D0
(en)
*
|
2006-02-23 |
2006-04-05 |
Novartis Ag |
Organic compounds
|
|
CA2671538A1
(en)
|
2006-12-14 |
2008-06-26 |
Leonard G. Presta |
Engineered anti-tslp antibody
|
|
ES2500066T3
(es)
*
|
2008-01-25 |
2014-09-30 |
Amgen, Inc |
Anticuerpos frente a ferroportina y métodos de uso
|
|
PH12012500843A1
(en)
*
|
2009-11-04 |
2019-07-10 |
Merck Sharp & Dohme |
Engineered anti-tslp antibody
|
|
WO2012040518A2
(en)
*
|
2010-09-22 |
2012-03-29 |
Amgen Inc. |
Carrier immunoglobulins and uses thereof
|
|
EP2773774A4
(en)
*
|
2011-11-03 |
2015-06-10 |
Merck Sharp & Dohme |
BIOMARKERS FOR TSLP TREATMENT
|
|
CN117264057A
(zh)
*
|
2012-04-27 |
2023-12-22 |
诺和诺德股份有限公司 |
人cd30配体抗原结合蛋白
|
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
|
WO2014144817A2
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Inc. |
Inhibitory polypeptides specific to wnt inhibitors
|
|
CN104371019B
(zh)
*
|
2013-08-13 |
2019-09-10 |
鸿运华宁（杭州）生物医药有限公司 |
一种能与glp-1r特异性结合的抗体及其与glp-1的融合蛋白质
|
|
TW201605896A
(zh)
|
2013-08-30 |
2016-02-16 |
安美基股份有限公司 |
Gitr抗原結合蛋白
|
|
EP3712166A1
(en)
|
2013-09-05 |
2020-09-23 |
Amgen Inc. |
Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
|
|
WO2015118124A1
(en)
*
|
2014-02-06 |
2015-08-13 |
Vib Vzw |
Thymic stromal lymphopoietin receptor antagonist
|
|
KR102496507B1
(ko)
|
2014-05-07 |
2023-02-03 |
암겐 인코포레이티드 |
충격 감소 요소들을 가진 자동 주사기
|
|
US10156562B2
(en)
|
2014-05-16 |
2018-12-18 |
Amgen Inc. |
Assay for detecting Th1 and Th2 cell populations
|
|
US20170103186A1
(en)
|
2014-06-03 |
2017-04-13 |
Amgen Inc. |
Systems and methods for supporting patient use of a drug delivery device
|
|
EP3206739B1
(en)
|
2014-10-14 |
2021-12-01 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
|
AU2015335743B2
(en)
|
2014-10-23 |
2020-12-24 |
Amgen Inc. |
Reducing viscosity of pharmaceutical formulations
|
|
US11357916B2
(en)
|
2014-12-19 |
2022-06-14 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
CA2976935C
(en)
|
2015-02-17 |
2020-03-10 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
|
EP3261690B1
(en)
|
2015-02-27 |
2021-12-15 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
|
BR112017019412A2
(pt)
*
|
2015-03-11 |
2018-05-02 |
Glaxosmithkline Ip Dev Ltd |
proteínas ligadoras de tslp
|
|
EA201792573A1
(ru)
|
2015-05-21 |
2018-04-30 |
Харпун Терапьютикс, Инк. |
Триспецифические связанные белки и способы их применения
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
JP6516925B2
(ja)
|
2015-09-09 |
2019-05-22 |
ノバルティス アーゲー |
胸腺間質性リンパ球新生因子（ｔｓｌｐ）結合性抗体および抗体を使用する方法
|
|
AU2016320748B2
(en)
*
|
2015-09-09 |
2019-05-02 |
Novartis Ag |
Thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of using the antibodies
|
|
US11351308B2
(en)
|
2015-12-09 |
2022-06-07 |
Amgen Inc. |
Auto-injector with signaling cap
|
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
TWI736575B
(zh)
|
2016-01-22 |
2021-08-21 |
美商默沙東藥廠 |
抗凝固因子ｘｉ抗體
|
|
GB201615588D0
(en)
*
|
2016-09-14 |
2016-10-26 |
Glaxosmithkline Ip Dev Ltd |
TSLP Binding Proteins
|
|
ES2814287T3
(es)
|
2016-03-15 |
2021-03-26 |
Amgen Inc |
Reducir la probabilidad de rotura de cristal en dispositivos de administración de fármaco
|
|
KR20180132766A
(ko)
*
|
2016-04-05 |
2018-12-12 |
브이아이비 브이지더블유 |
신규한 ｔｓｌｐ 저해인자
|
|
US11541168B2
(en)
|
2016-04-29 |
2023-01-03 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
WO2017192287A1
(en)
|
2016-05-02 |
2017-11-09 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
AU2017263558B2
(en)
|
2016-05-13 |
2022-12-22 |
Amgen Inc. |
Vial sleeve assembly
|
|
US11238150B2
(en)
|
2016-05-16 |
2022-02-01 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
JP7101621B2
(ja)
|
2016-05-20 |
2022-07-15 |
ハープーン セラピューティクス，インク． |
単一ドメイン血清アルブミン結合タンパク質
|
|
US11541176B2
(en)
|
2016-06-03 |
2023-01-03 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
IL263272B2
(en)
|
2016-06-14 |
2025-07-01 |
Merck Sharp & Dohme |
Antibodies to coagulation factor xi
|
|
WO2018004842A1
(en)
|
2016-07-01 |
2018-01-04 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
US10919966B2
(en)
*
|
2016-08-05 |
2021-02-16 |
Y-Biologics Inc. |
Antibody to programmed death-ligand 1 (PD-L1) and use thereof
|
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
WO2018081234A1
(en)
|
2016-10-25 |
2018-05-03 |
Amgen Inc. |
On-body injector
|
|
TWI857389B
(zh)
|
2016-12-01 |
2024-10-01 |
美商再生元醫藥公司 |
治療發炎症狀的方法
|
|
US20190358411A1
(en)
|
2017-01-17 |
2019-11-28 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
|
EP3383916B1
(en)
|
2017-01-24 |
2022-02-23 |
I-Mab Biopharma US Limited |
Anti-cd73 antibodies and uses thereof
|
|
US11752258B2
(en)
|
2017-02-17 |
2023-09-12 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
MX2019009755A
(es)
|
2017-02-17 |
2019-10-07 |
Amgen Inc |
Mecanismo de insercion para dispositivo de suministro de farmacos.
|
|
JP7377596B2
(ja)
|
2017-02-22 |
2023-11-10 |
アムジエン・インコーポレーテツド |
低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
|
|
CA3050927A1
(en)
|
2017-03-06 |
2018-09-13 |
Brian Stonecipher |
Drug delivery device with activation prevention feature
|
|
WO2018164829A1
(en)
|
2017-03-07 |
2018-09-13 |
Amgen Inc. |
Needle insertion by overpressure
|
|
MX2019010671A
(es)
|
2017-03-09 |
2019-10-21 |
Amgen Inc |
Mecanismo de insercion para dispositivo de administracion de farmacos.
|
|
AU2018235928B2
(en)
|
2017-03-14 |
2023-09-21 |
Amgen Inc. |
Control of total afucosylated glycoforms of antibodies produced in cell culture
|
|
SG11201907676PA
(en)
|
2017-03-28 |
2019-09-27 |
Amgen Inc |
Plunger rod and syringe assembly system and method
|
|
KR20240070727A
(ko)
|
2017-04-12 |
2024-05-21 |
암젠 인크 |
항-tslp 항체를 이용한 천식의 치료
|
|
MA48464A
(fr)
|
2017-04-28 |
2020-03-04 |
Amgen Inc |
Dipeptides n-acétylés et non acétylés contenant de l'arginine destinés à réduire la viscosité de compositions visqueuses de polypeptides thérapeutiques
|
|
EP3634539A1
(en)
|
2017-06-08 |
2020-04-15 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
MX2019014615A
(es)
|
2017-06-08 |
2020-02-07 |
Amgen Inc |
Dispositivo de administracion de farmacos accionado por par de torsion.
|
|
MX2019015472A
(es)
|
2017-06-22 |
2020-02-19 |
Amgen Inc |
Reduccion del impacto/choque de la activacion del mecanismo.
|
|
AU2018290302B2
(en)
|
2017-06-23 |
2024-02-29 |
Amgen Inc. |
Electronic drug delivery device comprising a cap activated by a switch assembly
|
|
CN109206514B
(zh)
*
|
2017-07-03 |
2019-10-08 |
拜西欧斯（北京）生物技术有限公司 |
Tslp单克隆抗体及其制备方法和应用
|
|
EP3651832B1
(en)
|
2017-07-14 |
2023-12-13 |
Amgen Inc. |
Needle insertion-retraction system having dual torsion spring system
|
|
US11672733B2
(en)
|
2017-07-21 |
2023-06-13 |
Amgen Inc. |
Gas permeable sealing member for drug container and methods of assembly
|
|
WO2019022950A1
(en)
|
2017-07-25 |
2019-01-31 |
Amgen Inc. |
DRUG DELIVERY DEVICE WITH CONTAINER ACCESS SYSTEM AND ASSEMBLY METHOD THEREOF
|
|
US11617837B2
(en)
|
2017-07-25 |
2023-04-04 |
Amgen Inc. |
Drug delivery device with gear module and related method of assembly
|
|
WO2019028191A1
(en)
|
2017-08-01 |
2019-02-07 |
Amgen Inc. |
SYSTEMS AND METHODS FOR PERFORMING REAL-TIME GLYCAN ASSAY OF A SAMPLE
|
|
SG11202000727SA
(en)
|
2017-08-01 |
2020-02-27 |
Amgen Inc |
Systems and methods for real time preparation of a polypeptide sample for analysis with mass spectrometry
|
|
MA49838A
(fr)
|
2017-08-09 |
2020-06-17 |
Amgen Inc |
Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre
|
|
CN110997939A
(zh)
|
2017-08-16 |
2020-04-10 |
免疫医疗有限责任公司 |
用于治疗特应性皮炎的组合物和方法以及治疗选择
|
|
US11077246B2
(en)
|
2017-08-18 |
2021-08-03 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
EP3691717B1
(en)
|
2017-10-04 |
2023-02-08 |
Amgen Inc. |
Flow adapter for drug delivery device
|
|
CN111132711B
(zh)
|
2017-10-06 |
2022-07-01 |
安进公司 |
带有联锁组件的药物递送装置及相关组装方法
|
|
IL273323B2
(en)
|
2017-10-09 |
2024-10-01 |
Amgen Inc |
Drug delivery device with drive assembly and related assembly method
|
|
HRP20241268T1
(hr)
|
2017-10-13 |
2024-12-06 |
Harpoon Therapeutics, Inc. |
Trispecifični proteini i postupci primjene
|
|
IL315737A
(en)
|
2017-10-13 |
2024-11-01 |
Harpoon Therapeutics Inc |
B-cell maturation antigen-binding proteins
|
|
MA50527A
(fr)
|
2017-11-03 |
2020-09-09 |
Amgen Inc |
Système et approches pour stériliser un dispositif d'administration de médicament
|
|
JP2021501616A
(ja)
|
2017-11-06 |
2021-01-21 |
アムジエン・インコーポレーテツド |
配置及び流量検出を備える薬物送達デバイス
|
|
IL273664B1
(en)
|
2017-11-06 |
2026-02-01 |
Amgen Inc |
Full-fledged assemblies and related methods
|
|
CA3079665A1
(en)
|
2017-11-10 |
2019-05-16 |
Amgen Inc. |
Plungers for drug delivery devices
|
|
MX2020004996A
(es)
|
2017-11-16 |
2020-08-27 |
Amgen Inc |
Un mecanismo de pestillo de puerta para un dispositivo de administracion de farmacos.
|
|
IL277106B2
(en)
|
2018-03-13 |
2024-03-01 |
Amgen Inc |
Sequential digestion of polypeptides for mass spectrometric analysis
|
|
ES3042632T3
(en)
|
2018-03-13 |
2025-11-24 |
Amgen Inc |
Methods for the preparation of trypsin-resistant polypeptides for mass spectrometric analysis
|
|
BR112020019559A2
(pt)
|
2018-03-26 |
2021-01-12 |
Amgen Inc. |
Glicoformas afucosiladas totais de anticorpos produzidos em cultura de células
|
|
KR20210020903A
(ko)
|
2018-05-14 |
2021-02-24 |
하푼 테라퓨틱스, 인크. |
면역글로불린 분자의 조건부 활성화를 위한 결합 모이어티
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
US12303677B2
(en)
|
2018-07-24 |
2025-05-20 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
|
MA53379A
(fr)
|
2018-07-24 |
2021-06-02 |
Amgen Inc |
Dispositifs d'administration pour l'administration de médicaments
|
|
EP3826699A1
(en)
|
2018-07-24 |
2021-06-02 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
CA3103105A1
(en)
|
2018-07-31 |
2020-02-06 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
|
WO2020061482A1
(en)
|
2018-09-21 |
2020-03-26 |
Harpoon Therapeutics, Inc. |
Egfr binding proteins and methods of use
|
|
MA53724A
(fr)
|
2018-09-24 |
2021-12-29 |
Amgen Inc |
Systèmes et procédés de dosage interventionnel
|
|
SG11202103022WA
(en)
|
2018-09-25 |
2021-04-29 |
Harpoon Therapeutics Inc |
Dll3 binding proteins and methods of use
|
|
MA53718A
(fr)
|
2018-09-28 |
2022-01-05 |
Amgen Inc |
Ensemble d'activation d'échappement de fil de muscle pour un dispositif d'administration de médicament
|
|
TWI857975B
(zh)
|
2018-10-02 |
2024-10-11 |
美商安進公司 |
具有內部力傳遞的用於藥物遞送之注射系統
|
|
TW202529830A
(zh)
|
2018-10-05 |
2025-08-01 |
美商安進公司 |
具有劑量指示器之藥物遞送裝置
|
|
MA53912A
(fr)
|
2018-10-15 |
2022-01-19 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un mécanisme d'amortissement
|
|
EA202191038A1
(ru)
|
2018-10-15 |
2021-07-06 |
Эмджен Инк. |
Способ платформенной сборки для устройства доставки лекарственного средства
|
|
EP3873566B1
(en)
|
2018-11-01 |
2024-11-27 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
AU2019370159B2
(en)
|
2018-11-01 |
2025-05-29 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
AU2019396614B2
(en)
|
2018-12-14 |
2025-07-10 |
Amgen Inc. |
System suitability method for use with protein concentration determination by slope
|
|
US11452738B2
(en)
|
2019-01-04 |
2022-09-27 |
Empirico Inc. |
Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcripts
|
|
US12352755B2
(en)
|
2019-02-14 |
2025-07-08 |
Amgen Inc. |
Systems and methods for preparing a sample and performing a real-time assay of the sample
|
|
US12493019B2
(en)
|
2019-02-20 |
2025-12-09 |
Amgen Inc. |
Methods of determining protein stability
|
|
US20230035363A1
(en)
|
2019-03-04 |
2023-02-02 |
Amgen Inc. |
In vivo reversibility of high molecular weight species
|
|
EP3948242A1
(en)
|
2019-03-27 |
2022-02-09 |
Amgen Inc. |
Methods of fingerprinting therapeutic proteins via a two-dimensional (2d) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products
|
|
WO2020219482A1
(en)
|
2019-04-24 |
2020-10-29 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
|
EP3981788A4
(en)
|
2019-06-04 |
2023-03-22 |
Jiangsu Hengrui Medicine Co., Ltd. |
ANTIBODY CAPABLE OF BINDING THYMIC STROMAL LYMPHOPOIETIN AND ITS USE
|
|
MA56121A
(fr)
|
2019-06-05 |
2022-04-13 |
Amgen Inc |
Procédés d'identification d'attributs de protéines thérapeutiques
|
|
JP7597784B2
(ja)
|
2019-07-11 |
2024-12-10 |
タヴォテック バイオセラピューティクス （ホン コン） リミテッド |
胸腺間質性リンパ球新生因子（ｔｓｌｐ）受容体シグナル伝達に干渉する薬剤
|
|
JP7608439B2
(ja)
|
2019-08-23 |
2025-01-06 |
アムジエン・インコーポレーテツド |
構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法
|
|
MX2022003461A
(es)
|
2019-09-26 |
2022-04-19 |
Amgen Inc |
Metodos de produccion de composiciones de anticuerpos.
|
|
LT4051708T
(lt)
|
2019-10-28 |
2025-04-10 |
Medimmune Limited |
Užkrūčio liaukos stromos limfopoetiną (tslp) surišančių antikūnų sausų miltelių pavidalo vaisto formos ir jų panaudojimo būdai
|
|
CN114887053B
(zh)
*
|
2019-11-29 |
2026-04-24 |
康诺亚生物医药科技（成都）有限公司 |
一种tslp相关病症治疗剂的开发和应用
|
|
MX2022004919A
(es)
*
|
2019-12-13 |
2022-05-16 |
Sichuan Kelun Biotech Biopharmaceutical Co Ltd |
Anticuerpo anti-linfopoyetina estromal timica (tslp) y sus usos.
|
|
TW202140550A
(zh)
|
2020-01-29 |
2021-11-01 |
瑞士商諾華公司 |
使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法
|
|
CN111171150B
(zh)
*
|
2020-02-05 |
2020-12-08 |
北京智仁美博生物科技有限公司 |
抗人tslp抗体及其用途
|
|
EP4103235A1
(en)
|
2020-02-13 |
2022-12-21 |
Amgen Inc. |
Formulations of human anti-tslp antibodies and methods of treating inflammatory disease
|
|
US20230073888A1
(en)
|
2020-02-13 |
2023-03-09 |
Amgen Inc. |
Treatment of atopic dermatitis with anti-tslp antibody
|
|
EP4106811A1
(en)
|
2020-02-18 |
2022-12-28 |
Amgen Inc. |
Formulations of human anti-tslp antibodies and methods of using the same
|
|
CN111662379B
(zh)
*
|
2020-05-09 |
2021-03-02 |
江苏省疾病预防控制中心(江苏省公共卫生研究院) |
抗新型冠状病毒的抗体、制备方法和应用
|
|
PH12022500025A1
(en)
*
|
2020-05-20 |
2024-03-25 |
Univ Columbia |
Potent neutralizing antibodies against sars-cov-2, generation and uses thereof
|
|
WO2021247892A1
(en)
|
2020-06-04 |
2021-12-09 |
Amgen Inc. |
Assessment of cleaning procedures of a biotherapeutic manufacturing process
|
|
WO2022061092A1
(en)
|
2020-09-18 |
2022-03-24 |
Amgen Inc. |
Methods of processing a sample for peptide mapping analysis
|
|
AU2021360897A1
(en)
|
2020-10-15 |
2023-05-25 |
Amgen Inc. |
Relative unpaired glycans in antibody production methods
|
|
WO2022098595A1
(en)
|
2020-11-05 |
2022-05-12 |
Amgen Inc. |
Materials and methods for protein processing
|
|
CN114437212B
(zh)
*
|
2020-11-06 |
2023-03-14 |
上海麦济生物技术有限公司 |
抗人胸腺基质淋巴细胞生成素抗体及其制备方法和应用
|
|
WO2022117079A1
(zh)
*
|
2020-12-03 |
2022-06-09 |
江苏恒瑞医药股份有限公司 |
结合胸腺基质淋巴细胞生成素的抗体及其应用
|
|
CN113501878B
(zh)
|
2021-02-03 |
2022-12-02 |
北京智仁美博生物科技有限公司 |
针对人tslp的多种抗体及其用途
|
|
CN115210258A
(zh)
*
|
2021-02-04 |
2022-10-18 |
舒泰神（北京）生物制药股份有限公司 |
特异性识别胸腺基质淋巴细胞生成素的抗体及其用途
|
|
WO2022226339A1
(en)
|
2021-04-23 |
2022-10-27 |
Amgen Inc. |
Anti-tslp antibody compositions and uses thereof
|
|
KR20230175245A
(ko)
|
2021-04-23 |
2023-12-29 |
암젠 인크 |
변형된 항-tslp 항체
|
|
KR20240011135A
(ko)
|
2021-05-21 |
2024-01-25 |
암젠 인크 |
약물 용기를 위한 충전 레시피를 최적화하는 방법
|
|
MX2023014306A
(es)
*
|
2021-05-30 |
2024-01-22 |
Biolojic Design Ltd |
Anticuerpos de union doble genomanipulados y sus usos.
|
|
EP4352094A1
(en)
|
2021-06-07 |
2024-04-17 |
Amgen Inc. |
Using fucosidase to control afucosylation level of glycosylated proteins
|
|
CN113069543B
(zh)
*
|
2021-06-07 |
2021-08-06 |
迈威(上海)生物科技股份有限公司 |
包含抗胸腺基质淋巴细胞生成素的单克隆抗体的液体组合物
|
|
CN113683694B
(zh)
|
2021-09-03 |
2022-05-13 |
江苏荃信生物医药股份有限公司 |
一种抗人tslp单克隆抗体及其应用
|
|
AU2022361382A1
(en)
|
2021-10-05 |
2024-03-28 |
Amgen Inc. |
Fc-gamma receptor ii binding and glycan content
|
|
WO2023070948A1
(zh)
*
|
2021-11-01 |
2023-05-04 |
江苏荃信生物医药股份有限公司 |
包含抗人胸腺基质淋巴细胞生成素(tslp)单克隆抗体的浓缩溶液的制备方法及液体制剂
|
|
CA3237662A1
(en)
|
2021-11-09 |
2023-05-19 |
Amgen Inc. |
Production of therapeutic proteins
|
|
CN117106084B
(zh)
*
|
2021-12-02 |
2024-03-22 |
北京东方百泰生物科技股份有限公司 |
一种抗tslp的单克隆抗体、其抗原结合片段及其应用
|
|
CN114369654B
(zh)
*
|
2021-12-21 |
2023-11-07 |
广州市妇女儿童医疗中心 |
川崎病的生物标志物及其应用
|
|
MX2024007966A
(es)
*
|
2021-12-24 |
2024-07-29 |
Inmagene Pte Ltd |
Anticuerpos anti-tslp novedosos.
|
|
US20240117030A1
(en)
*
|
2022-03-03 |
2024-04-11 |
Pfizer Inc. |
Multispecific antibodies and uses thereof
|
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
US12110324B2
(en)
|
2022-07-22 |
2024-10-08 |
Flagship Pioneering Innovations Vi, Llc |
Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)
|
|
CN118480118B
(zh)
*
|
2022-10-21 |
2025-08-19 |
珠海泰诺麦博制药股份有限公司 |
抗人巨细胞病毒抗体及其用途
|
|
TW202426485A
(zh)
|
2022-10-26 |
2024-07-01 |
美商安進公司 |
抗ｔｓｌｐ抗體組成物及其用途
|
|
TW202448501A
(zh)
|
2023-02-02 |
2024-12-16 |
美商麥迪紐有限責任公司 |
用抗ｔｓｌｐ抗體治療慢性鼻竇炎
|
|
WO2024174895A1
(zh)
*
|
2023-02-23 |
2024-08-29 |
四川科伦博泰生物医药股份有限公司 |
一种靶向tslp的单克隆抗体制剂
|
|
WO2024220916A1
(en)
|
2023-04-20 |
2024-10-24 |
Amgen Inc. |
Methods of determining relative unpaired glycan content
|
|
CN121443636A
(zh)
|
2023-05-18 |
2026-01-30 |
免疫医疗有限责任公司 |
用抗tslp抗体治疗皮质类固醇依赖性哮喘
|
|
CN121311767A
(zh)
|
2023-06-14 |
2026-01-09 |
百时美施贵宝公司 |
糖蛋白的近实时唾液酸定量
|
|
EP4731678A2
(en)
*
|
2023-06-22 |
2026-04-29 |
Paragon Therapeutics, Inc. |
Antibodies that bind tslp and tslpr and methods of use
|
|
WO2024264003A2
(en)
*
|
2023-06-22 |
2024-12-26 |
Paragon Therapeutics, Inc. |
Antibodies that bind interleukin 13 and tslp or tslpr and methods of use
|
|
WO2025038600A1
(en)
|
2023-08-14 |
2025-02-20 |
Amgen Inc. |
Methods for reducing yellow color
|
|
TW202525846A
(zh)
|
2023-08-25 |
2025-07-01 |
美商普羅特歐拉吉克適美國公司 |
抗ｉｌ—１３多特異性抗體構築體及其用途
|
|
AR134102A1
(es)
*
|
2023-10-12 |
2025-12-03 |
Innovent Biologics Suzhou Co Ltd |
ANTICUERPOS ANTI-IL-4Ra Y USOS DE LOS MISMOS
|
|
WO2025101602A1
(en)
|
2023-11-07 |
2025-05-15 |
Amgen Inc. |
Methods of analyzing amino acid content of a therapeutic protein
|
|
WO2025101820A1
(en)
|
2023-11-08 |
2025-05-15 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
WO2025147632A1
(en)
|
2024-01-05 |
2025-07-10 |
Medimmune, Llc |
Treatment of chronic obstructive pulmonary disease with anti-tslp antibody
|
|
WO2025221247A1
(en)
|
2024-04-17 |
2025-10-23 |
Amgen Inc. |
Treatment of eosinophilic esophagitis with anti-tslp antibody
|
|
WO2025255028A1
(en)
|
2024-06-03 |
2025-12-11 |
Amgen Inc. |
High-throughput liquid chromatography-mass spectrometry-based peptide mapping
|
|
WO2025264860A2
(en)
|
2024-06-18 |
2025-12-26 |
Yale University |
Methods of treating post-covid airway disease
|
|
WO2025265071A1
(en)
*
|
2024-06-21 |
2025-12-26 |
Paragon Therapeutics, Inc. |
Antibodies that bind tslp and methods of use
|
|
WO2026030152A1
(en)
|
2024-07-29 |
2026-02-05 |
Amgen Inc. |
System and method for assessing transferability of a fill recipe
|
|
WO2026067826A1
(zh)
*
|
2024-09-30 |
2026-04-02 |
深圳市小分子新药创新中心有限公司 |
抗tslp单域抗体及其衍生物
|